These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30885933)

  • 81. Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system.
    Jean-Pierre F; Hampton TH; Schultz D; Hogan DA; Groleau MC; Déziel E; O'Toole GA
    Elife; 2023 Jan; 12():. PubMed ID: 36661299
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
    Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
    J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.
    Qin X; Zerr DM; McNutt MA; Berry JE; Burns JL; Kapur RP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5971-81. PubMed ID: 22964251
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
    Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A
    PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
    Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
    Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.
    Manos J; Hu H; Rose BR; Wainwright CE; Zablotska IB; Cheney J; Turnbull L; Whitchurch CB; Grimwood K; Harmer C; Anuj SN; Harbour C;
    Eur J Clin Microbiol Infect Dis; 2013 Dec; 32(12):1583-92. PubMed ID: 23832143
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Fermentation products in the cystic fibrosis airways induce aggregation and dormancy-associated expression profiles in a CF clinical isolate of Pseudomonas aeruginosa.
    Phan J; Gallagher T; Oliver A; England WE; Whiteson K
    FEMS Microbiol Lett; 2018 May; 365(10):. PubMed ID: 29617986
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.
    Winstanley C; Fothergill JL
    FEMS Microbiol Lett; 2009 Jan; 290(1):1-9. PubMed ID: 19016870
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.
    Kramná L; Dřevínek P; Lin J; Kulich M; Cinek O
    Folia Microbiol (Praha); 2018 Mar; 63(2):237-248. PubMed ID: 29127619
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.
    Waters VJ; Kidd TJ; Canton R; Ekkelenkamp MB; Johansen HK; LiPuma JJ; Bell SC; Elborn JS; Flume PA; VanDevanter DR; Gilligan P;
    Clin Infect Dis; 2019 Oct; 69(10):1812-1816. PubMed ID: 31056660
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rapid diversification of
    Schick A; Kassen R
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10714-10719. PubMed ID: 30275334
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation.
    Ryall B; Carrara M; Zlosnik JE; Behrends V; Lee X; Wong Z; Lougheed KE; Williams HD
    PLoS One; 2014; 9(5):e96166. PubMed ID: 24852379
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
    Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pseudomonas aeruginosa infection of respiratory epithelium in a cystic fibrosis xenograft model.
    Cohn LA; Weber A; Phillips T; Lory S; Kaplan M; Smith A
    J Infect Dis; 2001 Mar; 183(6):919-27. PubMed ID: 11237809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.